Rizatriptan Benzoate Tablet
Product Images NDC 71335-2031

5 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 71335-2031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352031)

Label (Lbl713352031)
Label for Rizatriptan Benzoate 5 mg tablet, packaged by Bryant Ranch Prepack in Burbank, CA. The label references Maxalt 5 mg tablet blister pack for comparison and indicates a quantity of 30 tablets. Storage instructions specify room temperature between 20°-25°C (68°-77°F). The label displays a lot number, barcode, and the NDC number 71335-2031.*
FDA Label Image

Rizatriptan-fig-1 (Rizatriptan Fig 1)

Rizatriptan-fig-1 (Rizatriptan Fig 1)
A line chart depicting the estimated probability of response over time (hours post-dose) for Rizatriptan Benzoate 5 mg, Rizatriptan Benzoate 10 mg, and placebo. The graph shows a higher response probability for both Rizatriptan doses compared to placebo, increasing with time up to 2 hours post-dose.*
FDA Label Image

Rizatriptan-fig-2 (Rizatriptan Fig 2)

Rizatriptan-fig-2 (Rizatriptan Fig 2)
A line graph showing the estimated probability of medication or rescue over 24 hours post-dose for placebo, Rizatriptan Benzoate 5 mg, and Rizatriptan Benzoate 10 mg. The vertical axes represent probability percentages from 0 to 100%, while the horizontal axis shows hours post-dose from 0 to 24. The graph compares the effectiveness of the doses versus placebo.*
FDA Label Image

Rizatriptan-fig-5 (Rizatriptan Fig 5)

Rizatriptan-fig-5 (Rizatriptan Fig 5)
A line graph comparing the percent effect (with 95% confidence intervals) of Rizatriptan Benzoate versus placebo over time. The x-axis represents hours post the second dose, ranging from 0.5 to 2.0 hours, and the y-axis shows percentage values from 0 to 100. Rizatriptan Benzoate data points are represented by solid circles and placebo by open circles with dashed lines.*
FDA Label Image

Rizatriptan-structure (Rizatriptan Structure)

Rizatriptan-structure (Rizatriptan Structure)
Chemical structure diagram of Rizatriptan Benzoate showing the molecular arrangement and functional groups including an indole ring system and a benzoic acid moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.